Dr Georgios Daskalopoulos

• MD
• Phd

2003

• English
• Greek
• Bulgarian

• GMC
• ESC
• Hellenic Society of Cardiology

Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome? Daskalopoulos GN, Karkanaki A, Mikhailidis DP, Athyros VG. Angiology 2011; 62:285-90.

Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis erest

The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study. Athyros VG, Tziomalos K, Katsiki N, Gossios TD, Giouleme O, Anagnostis P, Pagourelias ED, Theocharidou E, Karagiannis A, Mikhailidis DP; GREACE Study Collaborative Group [Collaborators: Baharoudis G, Basdekas S, Bouloukos V, Christaki E, Daskalopoulos G, Dimopoulou S, Griva T, Kakafika A, Kargiotis K, Koumaras H, Mitsiou E, Papageorgiou A, Pehlivanidis A, Petridis D, Sfikas G, Sekeri Z, Skaperdas A, Symeonidis A.] Curr Vasc Pharmacol 2013;11:779-84.

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment. Daskalopoulos G, Karkanaki A, Piouka A, Prapas N, Panidis D, Gkeleris P, Athyros VG. Curr Vasc Pharmacol 2015;13:788-800.

The use and efficacy of FFR-CT, a real world multicentre audit of clinical data and cost analysis